mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.07 |
mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.06 |
0.07 |
mRNA |
BRD-A02303741 |
CTRPv2 |
pan-cancer |
AAC |
-0.075 |
0.07 |
mRNA |
Sildenafil |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.07 |
mRNA |
BIBW2992 |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.08 |
mRNA |
MI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.099 |
0.08 |
mRNA |
pluripotin |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.08 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
-0.082 |
0.08 |
mRNA |
ML162 |
CTRPv2 |
pan-cancer |
AAC |
-0.063 |
0.08 |
mRNA |
decitabine |
CTRPv2 |
pan-cancer |
AAC |
0.051 |
0.08 |